These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22089328)

  • 1. Rasburicase for hyperuricemia in hemolytic uremic syndrome.
    Acosta AA; Hogg RJ
    Pediatr Nephrol; 2012 Feb; 27(2):325-9. PubMed ID: 22089328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rasburicase improves the outcome of acute kidney injury from typical hemolytic uremic syndrome.
    Cho MH; Ahn YH; Lim SH; Kim JH; Ha IS; Cheong HI; Kang HG
    Pediatr Nephrol; 2020 Nov; 35(11):2183-2189. PubMed ID: 32561994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rasburicase in hemolytic uremic syndrome related to Shiga toxin-producing Escherichia coli: a report of nine cases.
    Balestracci A; Meni Battaglia L; Martin SM; Toledo I
    Pediatr Nephrol; 2020 Jun; 35(6):1133-1137. PubMed ID: 32152725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rasburicase improves hyperuricemia in infants with acute kidney injury.
    Hobbs DJ; Steinke JM; Chung JY; Barletta GM; Bunchman TE
    Pediatr Nephrol; 2010 Feb; 25(2):305-9. PubMed ID: 19936796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
    Bosly A; Sonet A; Pinkerton CR; McCowage G; Bron D; Sanz MA; Van den Berg H
    Cancer; 2003 Sep; 98(5):1048-54. PubMed ID: 12942574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury.
    Herrero-Goñi M; Zugazabeitia Irazábal A; Madariaga L; Chávarri Gil E; Gondra L; Aguirre Meñica M
    Clin Exp Nephrol; 2024 Jan; 28(1):13-22. PubMed ID: 37751013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
    Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
    J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
    Vines AN; Shanholtz CB; Thompson JL
    Ann Pharmacother; 2010 Oct; 44(10):1529-37. PubMed ID: 20841516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study.
    De Angelis S; Noce A; Di Renzo L; Cianci R; Naticchia A; Giarrizzo GF; Giordano F; Tozzo C; Splendiani G; De Lorenzo A
    Eur Rev Med Pharmacol Sci; 2007; 11(3):179-84. PubMed ID: 17970234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia.
    Vachhani P; Baron J; Freyer CW; Miller A; Wetzler M; Thompson JE; Griffiths EA; Wang ES
    Leuk Res; 2021 Aug; 107():106588. PubMed ID: 33957371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RASBURICASE TREATMENT FOR NEONATAL ACUTE KIDNEY INJURY - A CASE REPORT].
    Shasha-Lavsky H; Awadia P; Sheffer V; Weissman I
    Harefuah; 2021 Dec; 160(12):806-809. PubMed ID: 34957716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase.
    Hummel M; Reiter S; Adam K; Hehlmann R; Buchheidt D
    Eur J Haematol; 2008 Apr; 80(4):331-6. PubMed ID: 18081720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single 6-mg dose of rasburicase: The experience in a large academic medical center.
    Nauffal M; Redd R; Ni J; Stone RM; DeAngelo DJ; McDonnell AM
    J Oncol Pharm Pract; 2019 Sep; 25(6):1349-1356. PubMed ID: 30111244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasburicase versus intravenous allopurinol for non-malignancy-associated acute hyperuricemia in paediatric cardiology patients.
    Moss JD; Wu M; Axelrod DM; Kwiatkowski DM
    Cardiol Young; 2019 Sep; 29(9):1160-1164. PubMed ID: 31451121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
    Campara M; Shord SS; Haaf CM
    J Clin Pharm Ther; 2009 Apr; 34(2):207-13. PubMed ID: 19250141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea.
    Shin HY; Kang HJ; Park ES; Choi HS; Ahn HS; Kim SY; Chung NG; Kim HK; Kim SY; Kook H; Hwang TJ; Lee KC; Lee SM; Lee KS; Yoo KH; Koo HH; Lee MJ; Seo JJ; Moon HN; Ghim T; Lyu CJ; Lee WS; Choi YM
    Pediatr Blood Cancer; 2006 Apr; 46(4):439-45. PubMed ID: 16123985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose of rasburicase for treatment of hyperuricemia in acute kidney injury: a report of 3 cases.
    Hooman N; Otukesh H
    Iran J Kidney Dis; 2011 Mar; 5(2):130-2. PubMed ID: 21368393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.
    Pui CH; Mahmoud HH; Wiley JM; Woods GM; Leverger G; Camitta B; Hastings C; Blaney SM; Relling MV; Reaman GH
    J Clin Oncol; 2001 Feb; 19(3):697-704. PubMed ID: 11157020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients.
    Herrington JD; Dinh BC
    J Oncol Pharm Pract; 2015 Apr; 21(2):111-7. PubMed ID: 24549060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia.
    Martens KL; Khalighi PR; Li S; White AA; Silgard E; Frieze D; Estey E; Garcia DA; Hingorani S; Li A
    Leuk Res; 2020 Feb; 89():106298. PubMed ID: 31945598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.